ACADIA PHARMACEUTICALS INC (ACAD) has 167 open-market insider trades by 25 insiders since 2009. Over the last six months insiders net sold $114K. The most active filer is Stephen Davis, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| 14159, L.P. | Dir10% Owner | — | 1 | $200.0M | 2018-11-30 |
| 667, L.P. | Dir10% Owner | — | 4 | $158.6M | 2023-05-24 |
| Felix Baker | Dir10% Owner | — | 5 | $145.5M | 2023-01-12 |
| Baker Brothers Life Sciences LP | Dir10% Owner | — | 2 | $77.5M | 2019-09-20 |
| Julian Baker | Dir10% Owner | — | 1 | $75.0M | 2023-06-01 |
| Stephen Davis | CEO | — | 26 | $39.9M | 2024-08-19 |
| BAKER Bros. Advisors L.P. via Julian Baker | Dir10% Owner | — | 1 | $39.2M | 2026-05-29 |
| Bros Advisors Llc Baker | Dir10% | — | 1 | $29.9M | 2013-06-05 |
| Srdjan R. Stankovic | Pres | — | 18 | $20.2M | 2022-11-21 |
| Michael J. Yang | CCOVP | — | 9 | $12.8M | 2021-01-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark C. Schneyer | CFO & VP | Sell | $587K | 2026-08-05 |
| Elizabeth H.z. Thompson | VP | Sell | $433K | 2026-07-30 |
| James Kihara | CAO | Sell | $298K | 2026-06-26 |
| James Kihara | CAO | Sell | $114K | 2026-05-26 |
| Mark C. Schneyer | CFO & VP | Sell | $76K | 2026-05-04 |
| James Kihara | CAO | Sell | $29K | 2026-05-04 |
Companies that share insiders with ACAD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| James Kihara | CAO | Sell | $23K | 2026-04-07 |
| Mark C. Schneyer | CFO & VP | Sell | $60K | 2026-04-07 |
| Mark C. Schneyer | CFO & VP | Sell | $160K | 2026-03-25 |
| James Kihara | CAO | Sell | $42K | 2026-03-25 |
| Jennifer J. Rhodes | CLO & VP +1 | Sell | $83K | 2026-03-25 |
| Elizabeth H.z. Thompson | VP | Sell | $74K | 2026-03-25 |
| Catherine Owen Adams | CEO | Sell | $250K | 2026-03-25 |
| Jennifer J. Rhodes | CLO & EVP +1 | Sell | $162K | 2026-02-09 |
| Mark C. Schneyer | CFO & VP | Sell | $486K | 2025-11-18 |